v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional paid-in capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2024   121,599,488      
Beginning balance at Dec. 31, 2024 $ 287,618 $ 12 $ 388,979 $ 27 $ (101,400)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (18,200)       (18,200)
Share-based compensation 4,144   4,144    
Issuance of common stock under stock compensation plans (in shares)   535,453      
Issuance of common stock under stock compensation plans 44   44    
Unrealized net loss on available-for-sale securities (19)     (19)  
ATM facility issuance costs (71)   (71)    
Ending balance (in shares) at Mar. 31, 2025   122,134,941      
Ending balance at Mar. 31, 2025 273,516 $ 12 393,096 8 (119,600)
Beginning balance (in shares) at Dec. 31, 2024   121,599,488      
Beginning balance at Dec. 31, 2024 287,618 $ 12 388,979 27 (101,400)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (34,075)        
Unrealized net loss on available-for-sale securities (29)        
Ending balance (in shares) at Jun. 30, 2025   122,701,294      
Ending balance at Jun. 30, 2025 262,064 $ 12 397,529 (2) (135,475)
Beginning balance (in shares) at Mar. 31, 2025   122,134,941      
Beginning balance at Mar. 31, 2025 273,516 $ 12 393,096 8 (119,600)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (15,875)       (15,875)
Share-based compensation 4,111   4,111    
Issuance of common stock under stock compensation plans (in shares)   566,353      
Issuance of common stock under stock compensation plans 297   297    
Unrealized net loss on available-for-sale securities (10)     (10)  
ATM facility issuance costs 25   25    
Ending balance (in shares) at Jun. 30, 2025   122,701,294      
Ending balance at Jun. 30, 2025 262,064 $ 12 397,529 (2) (135,475)
Beginning balance (in shares) at Dec. 31, 2025   144,308,383      
Beginning balance at Dec. 31, 2025 267,027 $ 14 433,180 12 (166,179)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (7,707)       (7,707)
Share-based compensation 3,340   3,340    
Issuance of common stock under stock compensation plans (in shares)   475,430      
Unrealized net loss on available-for-sale securities (14)     (14)  
Ending balance (in shares) at Mar. 31, 2026   144,783,813      
Ending balance at Mar. 31, 2026 262,646 $ 14 436,520 (2) (173,886)
Beginning balance (in shares) at Dec. 31, 2025   144,308,383      
Beginning balance at Dec. 31, 2025 267,027 $ 14 433,180 12 (166,179)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (13,566)        
Unrealized net loss on available-for-sale securities (32)        
Ending balance (in shares) at Jun. 30, 2026   145,390,398      
Ending balance at Jun. 30, 2026 260,274 $ 15 440,024 (20) (179,745)
Beginning balance (in shares) at Mar. 31, 2026   144,783,813      
Beginning balance at Mar. 31, 2026 262,646 $ 14 436,520 (2) (173,886)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (5,859)       (5,859)
Share-based compensation 3,159   3,159    
Issuance of common stock under stock compensation plans (in shares)   606,585      
Issuance of common stock under stock compensation plans 346 $ 1 345    
Unrealized net loss on available-for-sale securities (18)     (18)  
Ending balance (in shares) at Jun. 30, 2026   145,390,398      
Ending balance at Jun. 30, 2026 $ 260,274 $ 15 $ 440,024 $ (20) $ (179,745)